RZLT
Rezolute
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RZLT Profile
Rezolute, Inc.
A clinical-stage biopharmaceutical company that develops drug therapies for the treatment of metabolic diseaes
275 Shoreline Drive, Suite 500, Redwood City, California 94065
--
Rezolute, Inc., was incorporated in Delaware in 2010 and re-incorporated in Nevada in June 2021. The company is a clinical-stage biopharmaceutical company developing therapies for metabolic diseases associated with chronic glucose imbalance. The company's main clinical asset, RZ358, is a potential drug for the treatment of congenital hyperinsulinemia, an extremely rare pediatric genetic disease characterized by the pancreas producing too much insulin.